Sandra Rojas-Caro

Insider Reports History

Entity
Individual
Location
C/O Aeglea Biotherapeutics, Inc., 901 S. Mopac Expressway, Ste. 250, Austin, TX
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Sandra Rojas-Caro
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Rojas-Caro:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuBase Therapeutics, Inc. Chief Medical Officer Employee stock option (right to buy) 44.6K Jan 24, 2022 Direct

Insider Reports Filed by Sandra Rojas-Caro

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBSE NeuBase Therapeutics, Inc. Jan 24, 2022 1 $0 4 Jan 25, 2022 Chief Medical Officer
NBSE NeuBase Therapeutics, Inc. May 24, 2021 1 $0 4 May 25, 2021 Chief Medical Officer
NBSE NeuBase Therapeutics, Inc. May 24, 2021 0 $0 3 May 25, 2021 Chief Medical Officer